Financials
- Market Capitalization 166.01 M
- Employee 36
- Founded 2009
- CEO N/A
- Website www.corbuspharma.com
- Headquarter Delaware, United States
- FIGI BBG0078PJKQ7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.64
ratio cours/chiffre d'affaires
24.01
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3742 | PEPG PepGen Inc. - Common Stock | 2.41 USD | -1.23% | +18.72% | +47.85% | +91.27% | 166.70 M USD | ||
| 3744 | ALEC Alector, Inc. - Common Stock | 1.50 USD | +7.91% | -18.03% | +2.04% | -5.66% | 166.54 M USD | ||
| 3746 | ANTX AN2 Therapeutics, Inc. - Common Stock | 4.66 USD | -2.10% | +5.67% | -5.48% | +339.62% | 167.84 M USD | ||
| 3752 | ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.21 USD | -12.65% | -19.05% | -5.56% | +66.17% | 159.62 M USD |